A Phase 2/3 Study of Efgartigimod PH20 SC in Adult Participants with Bullous Pemphigoid – BALLAD study Webinar

A Phase 2/3 Study of Efgartigimod PH20 SC in Adult Participants with Bullous Pemphigoid – BALLAD study is the focus of the November 16th webinar.

Event Image
Nov 16, 2022 @

A Phase 2/3 Study of Efgartigimod PH20 SC in Adult Participants with Bullous Pemphigoid – BALLAD study